Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RCKT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
26 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 29 days ago
Red flags: 12
179 filers reported a long position in RCKT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RTW INVESTMENTS, LP | $60.5M | 17.7M | Unchanged |
| BlackRock, Inc. | $33.9M | 9.9M | +26.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.9M | 5.8M | +23.9% |
| CITIGROUP INC | $16.6M | 4.9M | -4.7% |
| MARSHALL WACE, LLP | $13.8M | 4M | +32.6% |
| MILLENNIUM MANAGEMENT LLC | $13.7M | 4M | +28.3% |
| Newtyn Management, LLC | $13.7M | 4M | +26.3% |
| MAVERICK CAPITAL LTD | $13.4M | 3.9M | +10% |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.9M | 3.8M | +0.2% |
| AQR CAPITAL MANAGEMENT LLC | $11.6M | 3.4M | +10.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.